Titre : | Drug Abuse Warning Network: development of a new design. Methodology report |
Titre traduit : | (Réseau d'alerte concernant l'abus de drogues : développement d'une nouvelle étude. Rapport méthodologique) |
Auteurs : | SAMHSA |
Type de document : | Rapport |
Editeur : | Rockville, MD : SAMHSA, Office of Applied Studies (OAS), 2002 |
Collection : | Methodology Series, num. M-4 |
Format : | 126 p. |
Langues: | Français |
Discipline : | SAN (Santé publique / Public health) |
Mots-clés : |
Thésaurus géographique ETATS-UNISThésaurus mots-clés METHODE ; PSYCHOTROPES ; ABUS ; SURVEILLANCE EPIDEMIOLOGIQUE ; PARTENARIAT ; URGENCE ; HOPITAL ; DISPOSITIF DE SOIN ; DIAGNOSTIC ; PROTECTION SOCIALE |
Résumé : | The Drug Abuse Warning Network (DAWN) is an important source of national and local information on substance abuse. This information is derived from data on visits to hospital emergency departments (EDs) and drug-related deaths reviewed by medical examiners and coroners (ME/Cs). DAWN collects data on the demographic characteristics of substance abusers and the specific drugs involved in each drug-related ED visit or death. The detail available on specific drugs is not matched by any other data system. Currently, DAWN is managed by the Office of Applied Studies (OAS), a component of the Substance Abuse and Mental Health Services Administration (SAMHSA) within the U.S. Department of Health and Human Services. SAMHSA is directed under Section 505 of the Public Health Service Act (42 U.S.C. 290aa-4(c)(1) to collect such data. Mindful of these limitations, SAMHSA convened the 1997 review panel to consider the utility of DAWN and whether changes in the health care delivery system, particularly the growth of managed care, had diluted the value of emergency departments as a setting for collecting data on drug abuse. The panel, which could have called for DAWN's elimination, recommended instead that SAMHSA update its procedures and prepare DAWN for the 21st century. In response, OAS undertook the comprehensive two-year evaluation of DAWN. This evaluation resulted in recommendations for a new design for DAWN. Using a wide range of study methods, the evaluation addressed the following questions: Who are the users of DAWN data and what information do they need? Does DAWN collect data from the right settings? Does DAWN collect data on the right set of patients? Does DAWN collect the right data on those patients? How can DAWN use technology to collect data more efficiently? How can DAWN deliver information more effectively? These questions challenged the fundamental approaches long used by this survey. This publication presents some of the findings used to improve DAWN's design, guided by these important questions. The first chapter discusses the development of an alternative design to DAWN, including limitations of the current design, the scope of the redesign activities, and key issues. The second chapter assesses the impact of health system change on DAWN, through a comprehensive review of the literature, analyses of national data, and qualitative research on local health system impacts. The third chapter discusses the development of a new sample design for DAWN. Finally, the fourth chapter discusses the redesign of DAWN's case definitions, data elements, and case screening procedures. (Extract of the publication) |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 2 |
Affiliation : | USA |
Numéro Toxibase : | 1301144 |
URL : | https://www.samhsa.gov/data/sites/default/files/DAWN2k11ED/DAWN2k11ED/rpts/DAWN2k11-Methods-Report.htm |
Lien : | https://www.webharvest.gov/peth04/20041016214913/http://dawninfo.samhsa.gov/pubs_94_02/methodology/files/report.pdf |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil